707 related articles for article (PubMed ID: 11600554)
1. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study).
Meier C; Staub JJ; Roth CB; Guglielmetti M; Kunz M; Miserez AR; Drewe J; Huber P; Herzog R; Müller B
J Clin Endocrinol Metab; 2001 Oct; 86(10):4860-6. PubMed ID: 11600554
[TBL] [Abstract][Full Text] [Related]
2. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study.
Iqbal A; Jorde R; Figenschau Y
J Intern Med; 2006 Jul; 260(1):53-61. PubMed ID: 16789979
[TBL] [Abstract][Full Text] [Related]
3. A Worthy Finding: Decrease in Total Cholesterol and Low-Density Lipoprotein Cholesterol in Treated Mild Subclinical Hypothyroidism.
Zhao M; Liu L; Wang F; Yuan Z; Zhang X; Xu C; Song Y; Guan Q; Gao L; Shan Z; Zhang H; Zhao J
Thyroid; 2016 Aug; 26(8):1019-29. PubMed ID: 27270263
[TBL] [Abstract][Full Text] [Related]
4. Age and gender substantially influence the relationship between thyroid status and the lipoprotein profile: results from a large cross-sectional study.
Tognini S; Polini A; Pasqualetti G; Ursino S; Caraccio N; Ferdeghini M; Monzani F
Thyroid; 2012 Nov; 22(11):1096-103. PubMed ID: 23050788
[TBL] [Abstract][Full Text] [Related]
5. Effect of levo-thyroxine replacement on non-high-density lipoprotein cholesterol in hypothyroid patients.
Ito M; Arishima T; Kudo T; Nishihara E; Ohye H; Kubota S; Fukata S; Amino N; Kuma K; Sasaki I; Hiraiwa T; Hanafusa T; Takamatsu J; Miyauchi A
J Clin Endocrinol Metab; 2007 Feb; 92(2):608-11. PubMed ID: 17148561
[TBL] [Abstract][Full Text] [Related]
6. Lipid profile in subclinical hypothyroidism: is L-thyroxine substitution beneficial?
Efstathiadou Z; Bitsis S; Milionis HJ; Kukuvitis A; Bairaktari ET; Elisaf MS; Tsatsoulis A
Eur J Endocrinol; 2001 Dec; 145(6):705-10. PubMed ID: 11720894
[TBL] [Abstract][Full Text] [Related]
7. Prolactin dysregulation in women with subclinical hypothyroidism: effect of levothyroxine replacement therapy.
Meier C; Christ-Crain M; Guglielmetti M; Huber P; Staub JJ; Müller B
Thyroid; 2003 Oct; 13(10):979-85. PubMed ID: 14611708
[TBL] [Abstract][Full Text] [Related]
8. Thyroxine replacement therapy and circulating lipid concentrations.
Franklyn JA; Daykin J; Betteridge J; Hughes EA; Holder R; Jones SR; Sheppard MC
Clin Endocrinol (Oxf); 1993 May; 38(5):453-9. PubMed ID: 8330440
[TBL] [Abstract][Full Text] [Related]
9. Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment.
Tzotzas T; Krassas GE; Konstantinidis T; Bougoulia M
Thyroid; 2000 Sep; 10(9):803-8. PubMed ID: 11041458
[TBL] [Abstract][Full Text] [Related]
10. Changes in plasma low-density lipoprotein (LDL)- and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thyroxine, not to polymorphisms in LDL receptor or cholesterol ester transfer protein genes.
Diekman MJ; Anghelescu N; Endert E; Bakker O; Wiersinga WM
J Clin Endocrinol Metab; 2000 May; 85(5):1857-62. PubMed ID: 10843165
[TBL] [Abstract][Full Text] [Related]
11. Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo- controlled study.
Monzani F; Caraccio N; Kozàkowà M; Dardano A; Vittone F; Virdis A; Taddei S; Palombo C; Ferrannini E
J Clin Endocrinol Metab; 2004 May; 89(5):2099-106. PubMed ID: 15126526
[TBL] [Abstract][Full Text] [Related]
12. Increased atherogenic low-density lipoprotein cholesterol in untreated subclinical hypothyroidism.
Mikhail GS; Alshammari SM; Alenezi MY; Mansour M; Khalil NA
Endocr Pract; 2008; 14(5):570-5. PubMed ID: 18753099
[TBL] [Abstract][Full Text] [Related]
13. How selective are the new guidelines for treatment of subclinical hypothyroidism for patients with thyrotropin levels at or below 10 mIU/L?
Rosario PW; Calsolari MR
Thyroid; 2013 May; 23(5):562-5. PubMed ID: 23627903
[TBL] [Abstract][Full Text] [Related]
14. The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial.
Razvi S; Ingoe L; Keeka G; Oates C; McMillan C; Weaver JU
J Clin Endocrinol Metab; 2007 May; 92(5):1715-23. PubMed ID: 17299073
[TBL] [Abstract][Full Text] [Related]
15. Evaluation response and effectiveness of thyroid hormone replacement treatment on lipid profile and function in elderly patients with subclinical hypothyroidism.
Arinzon Z; Zuta A; Peisakh A; Feldman J; Berner Y
Arch Gerontol Geriatr; 2007; 44(1):13-9. PubMed ID: 16621071
[TBL] [Abstract][Full Text] [Related]
16. Association of Subclinical Hypothyroidism with Dyslipidemia and Increased Carotid Intima-Media Thickness in Children.
Unal E; Akın A; Yıldırım R; Demir V; Yildiz İ; Haspolat YK
J Clin Res Pediatr Endocrinol; 2017 Jun; 9(2):144-149. PubMed ID: 28008862
[TBL] [Abstract][Full Text] [Related]
17. Impaired action of thyroid hormone associated with smoking in women with hypothyroidism.
Müller B; Zulewski H; Huber P; Ratcliffe JG; Staub JJ
N Engl J Med; 1995 Oct; 333(15):964-9. PubMed ID: 7666915
[TBL] [Abstract][Full Text] [Related]
18. Lipid profile in different degrees of hypothyroidism and effects of levothyroxine replacement in mild thyroid failure.
Teixeira Pde F; Reuters VS; Ferreira MM; Almeida CP; Reis FA; Buescu A; Costa AJ; Vaisman M
Transl Res; 2008 Apr; 151(4):224-31. PubMed ID: 18355770
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum lipoprotein(a) in subclinical hypothyroidism.
Kung AW; Pang RW; Janus ED
Clin Endocrinol (Oxf); 1995 Oct; 43(4):445-9. PubMed ID: 7586619
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study.
Caraccio N; Ferrannini E; Monzani F
J Clin Endocrinol Metab; 2002 Apr; 87(4):1533-8. PubMed ID: 11932277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
